Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Minerva Neurosciences Inc. | 0 | 9 | 0 | 3 | €2.76 | - | - |
| Trevena Inc. | 2 | 20 | 0 | 2 | €0.15 | €6.48 | 4192.715% |
| Moleculin Biotech Inc | 3 | 23 | 0 | 1 | €0.41 | €18.42 | 4393.659% |
| Organovo Holdings Inc. | 0 | 8 | 0 | 1 | €0.48 | - | - |
| Evoke Pharma Inc. | 0 | 24 | 0 | 1 | €0.38 | - | - |
| Cara Therapeutics Inc. | 11 | 4 | 0 | 1 | €0.32 | €4.62 | 1349.498% |
| Chimerix Inc. | 3 | 1 | 0 | 0 | €0.78 | €5.51 | 610.644% |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €0.95 | €6.49 | 584.124% |
| Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | €0.39 | - | - |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.25 | €50.00 | 3909.623% |
| Glycomimetics Inc. | 5 | 3 | 0 | 0 | €0.20 | €7.35 | 3579.479% |
| Mirati Therapeutics Inc. | 2 | 10 | 0 | 0 | €53.84 | €78.43 | 45.666% |
| Bristol-Myers Squibb | 7 | 2 | 0 | 0 | €44.42 | €70.25 | 58.173% |
| Inotiv Inc. | 3 | 1 | 0 | 0 | €1.78 | €10.66 | 498.972% |
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €5.40 | - | - |
| Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | €7.70 | €110.00 | 1328.571% |
| Sage Therapeutics Inc. | 8 | 4 | 1 | 0 | €9.00 | €25.88 | 187.529% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.37 | €3.00 | 716.549% |
| Coherus Bioscien. | 1 | 2 | 0 | 0 | €1.24 | - | - |
| Fibrogen Inc. | 1 | 2 | 1 | 0 | €0.48 | €4.00 | 735.247% |
| Bellicum Pharmaceuticals Inc. | 0 | 12 | 0 | 0 | €0.064 | - | - |
| Vaxart Inc. | 0 | 1 | 0 | 0 | €0.61 | - | - |
| Agenus Inc. | 4 | 2 | 0 | 0 | €0.41 | €37.02 | 8846.834% |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €1.12 | - | - |
| Ironwood Pharmaceuticals | 8 | 1 | 0 | 0 | €6.15 | €18.80 | 205.644% |